A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination with Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504709-35-00

Acronym

GO43860

Enrollment

Registered

2024-01-15

Start date

2023-08-16

Completion date

Unknown

Last updated

2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally advanced or metastatic solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Greece, Netherlands, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026